Morados, Ricky F.

HRN: 29-08-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/10/2026
06/16/2026
IV
1.5gm
Q8
For Wound Debridment
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines